Vascular targeting of nanocarriers: perplexing aspects of the seemingly straightforward paradigm.

Abstract excerpt

Targeted nanomedicine holds promise to find clinical use in many medical areas. Endothelial cells that line the luminal surface of blood vessels represent a key target for treatment of inflammation, ischemia, thrombosis, stroke, and other neurological, cardiovascular, pulmonary, and oncological conditions. In other cases, the endothelium is a barrier for tissue penetration or a victim of adverse effects. Several...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Cell Adhesion Molecules
• Share to Drug Delivery Systems